PDS Biotech to host KOL event on PDS0301 in advanced liver metastases

PDS Biotech will host a virtual KOL event on Oct. 15, 2026, discussing Phase 2 clinical outcomes for PDS0301 in advanced liver-associated cancers, including metastatic colorectal cancer.